Plunkett Research Online: NextCure Inc

NEXTCURE INC (NXTC:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

NextCure, Inc. is a clinical-stage biopharmaceutical company that discovers and develops novel, first-in-class immuno-medicines to treat cancer and other immune-related diseases via restoring normal immune function. Through its proprietary Functional Integrated NextCure Discovery in Immuno-Oncology.....



NextCure Inc
Ticker: NXTC
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 240 399-4900
Fax:
Address: 9000 Virginia Manor Road
Suite 200
Beltsville, MD 20705 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
Contacts Description

Michael Richman CEO/Director/President
Steven Cobourn CFO
See More
NextCure, Inc. is a clinical-stage biopharmaceutical company that discovers and develops novel, first-in-class immuno-medicines to treat cancer and other immune-related diseases via restoring normal immune function. Through its proprietary Functional Integrated NextCure Discovery in Immuno-Oncology.....See More See More

Auditor: EY
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2020 2019 2018 2017
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
FIND-IO
NC318
NC410
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: